Pharmaceutical Technology6 天
XYF-19 by Xi’An Yufan Biotechnology for Hairy Cell Leukemia: Likelihood of Approval
XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Hairy Cell Leukemia.
Pharmaceutical Technology12 天
XYF-19 by Xi’An Yufan Biotechnology for Marginal Zone B-cell Lymphoma: Likelihood of Approval
XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Marginal Zone B-cell Lymphoma.
来自MSN1 个月
Community rallies around Metro East paramedic battling rare form of cancer
When they did the bone biopsy is when they found out he has hairy cell leukemia,” paramedic Nick Fensom said. "Hairy cell is a form of blood cancer that basically affects the red blood cells.